The implication is that a monoclonal (and therefore specific) antibody may bind to an area of VWF responsible for ristocetin cofactor activity. Antibody-VWF complexes appear to be rapidly cleared from the circulation.
In our case a circulating monoclonal lambda light chain presumably bound to VWF resulting in loss of high molecular weight multimers. Obvious inhibiton of VWF:Ag, VIII:C or VWF:RCoF activity in pooled normal plasma was not detected by mixing studies. Use of prednisone is felt to have suppressed production of the paraprotein. The low immunoglobulin levels in association with osteopenia and a vertebral crush fracture which developed later were suggestive of multiple myeloma despite the normal bone marrow.
Of interest, the bleeding time in our patients was normal (a finding previously reported'3 but never satisfactorily explained). It has been postulated that this may be due to normal concentration of platelet VWF.
The association of angiodysplasia with VWS has been reported'7"8 and was noted in our patient. It is unclear whether or not this is a chance association.
Treatment is best directed at the underlying disease as previously demonstrated in cases secondary to SLE, Wilms' tumour and myeloproliferative disorder amongst others. Specific treatment includes DDAVP, cryoprecipitate and, recently, intravenous gammaglobulin. 2 Based on this case, a trial of prednisone may be indicated in patients presenting with monoclonal gammopathy and acquired VWS.
We believe this to be the first reported case of acquired VWS in association with free lambda light chains.
